Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Development of UGGT1 inhibitors as broad-spectrum antivirals, Nicole Zitzmann (Department of Biochemistry)
  • Development of an adeno-associated viral vectored immunoprophylactic strategy against blood-stage Plasmodium vivax Malaria, Martino Bardelli (Jenner Institute, Nuffield Department of Medicine)
  • Developing small molecule inhibitors for a rare childhood seizure disorder, Wyatt Yue (Nuffield Department of Medicine, Structural Genomics Consortium)
  • Harnessing the properties of a small compound to improve the efficiency of reprogramming dendritic cells to pluripotencyPaul Fairchild (Sir William Dunn School of Pathology)
  • Deep Brain Stimulation for Multiple System Atrophy, Alex Green (Nuffield Department of Surgical Sciences)
  • Structure-guided design of FAM83B inhibitors for triple negative breast cancer, Alex Bullock (Nuffield Department of Medicine)
  • MICA: Reprogramming tumor immunity by targeting tenascin-C, Kim Midwood (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences)
  • T-cell receptor-like antibodies targeting p53, Alison Banham (Radcliffe Department of Medicine)
  • Polymer-DNA nanoparticles for Therapeutic Intracellular Delivery, Andrew Turberfield (Department of Physiology, Anatomy and Genetics)
  • Orthotopic colorectal cancer patient-derived xenograft models to test therapeutic manipulation ofGREM1, Simon Leedham (Nuffield Department of Medicine)
  • Structure-Guided Design of Sonic Hedgehog Morphogen Inhibitors, Christian Siebold (Nuffield Department of Medicine)
  • Proof-of-concept controlled human infection with Plasmodium vivax malaria to accelerate Phase II clinical trials of vaccine candidates, Angela Minassian (Nuffield Department of Medicine)
  • How does BCG vaccination facilitate protection against malaria? Anita Milicic (Nuffield Department of Medicine)
  • CMV-vectored vaccines: second generation vectors with improved safety profile, Sarah Sebastian (Nuffield Department of Medicine)
  • Development of a novel bivalent vaccine to prevent both Salmonella Typhi and Paratyphi infections, Christine Rollier (Department of Paediatrics)
  • Ultrasonic electrospray of intact complexes from vesicles and exosomes, Carol Robinson (Department of Chemistry - Mathematical, Physical & Life Sciences Division)
  • Non-invasive estimation of pulmonary blood flow in primary pulmonary hypertension, Peter Robbins (Department of Physiology, Anatomy and Genetics)
  • New approaches to microsphere formulation for single dose prime-boost vaccine delivery, Anita Milicic (Nuffield Department of Medicine)
  • Utilising immune-dominant epitopes of limited variability to create a novel influenza vaccine, Sunetra Gupta; Department of Zoology - Mathematical, Physical & Life Sciences Division)
  • Development of UGGT1 inhibitors as broad-spectrum antivirals, Nicole Zitzmann (Department of Biochemistry)
  • The development of pan-genotypic Hepatitis C virus vaccine generating T and B cell immunity, Eleanor Barnes (Radcliffe Department of Medicine)
  • A universal H1N1 influenza vaccine using an epitope of limited variability: Sunetra Gupta; Department of Zoology - Mathematical, Physical & Life Sciences Division)
  • A flexible and scalable platform for creating novel medicinal macrocycles, James Naismith (Nuffield Department of Medicine)
  • Pre-clinical development of therapeutic cross-reactive monoclonal antibodies to Ebola viruses, Pramila Rijal (Radcliffe Department of Medicine)
  • Structure based beta-Lactamase resistant transpeptidase inhibitors to address antibiotic resistance: Christopher Schofield (Department of Chemistry - Mathematical, Physical & Life Sciences Division)
  • Polymeric-DNA nanoparticles: modular delivery systems for nucleic acid-based therapies: Andrew J Turberfield (Department of Physics - Mathematical, Physical & Life Sciences Division)
  • Measuring lung inhomogeneity in paediatric cystic fibrosis, Grant A.D. Ritchie (Department of Chemistry - Mathematical, Physical & Life Sciences Division)
  • Universal Big DNA assembly: transition to a translatable high throughput process, Christopher O'Callaghan (Nuffield Department of Medicine)
  • Using DNA-based diagnostics to prevent death of children with blood disorders in sub-Saharan Africa, Anna Schuh (Department of Oncology)
  • Using genome variation to sort extremely rare cell populations for clinical application, John Frater (Nuffield Department of Medicine)
  • Antibody-mediated oligonucleotide delivery to brain for neurodegenerative disease, Suzan Hammond (Department of Paediatrics)
  • CAT&MAUS: simultaneous imaging and analysis of joint motion for clinical assessment: Stephen Mellon (Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences)
  • GAPDH and extracellular vesicles: biological nanoparticles for therapy of neurodegenerative diseases: Ghulam Dar (Department of Paediatrics)
  • Proteomic biomarkers in IBD, Alexander Adams(Nuffield Department of Medicine)